wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q40063670-9272DB44-61F2-4274-B500-AF34B6C107C4
Q40063670-9272DB44-61F2-4274-B500-AF34B6C107C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40063670-9272DB44-61F2-4274-B500-AF34B6C107C4
Synergism between bosutinib (SKI-606) and the Chk1 inhibitor (PF-00477736) in highly imatinib-resistant BCR/ABL⁺ leukemia cells.
P2860
Q40063670-9272DB44-61F2-4274-B500-AF34B6C107C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40063670-9272DB44-61F2-4274-B500-AF34B6C107C4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9391b5c6e3444a4ff684ca004c267833808a05a3
P2860
Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors